Projects per year
Personal profile
Personal profile
While completing her postdoctoral training, Dr. Greene studied under the renowned Dr. Stanley Appel, the current chair of the Department of Neurology at Houston Methodist Hospital and the founder of the Houston Methodist Neurological Institute. After completion of a fellowship in Dr. Appel’s laboratory, she became a tenure track Associate Professor of Neurology at the Baylor College of Medicine in Houston, Texas. Dr. Greene is a member of the American Academy of Neurology, the American Board of Psychiatry and Neurology, and a recipient of the Robert Wood Johnson Foundation’s Minority Medical Faculty Development Program. She joined the Houston Methodist Specialty Physician Group in 2005.
Research interests
Dr. Greene's research aims to characterize the peripheral immune inflammatory response in ALS and other neurodegenerative diseases, and identify the potential markers that may reflect disease activity and progression. Her translational research seeks to identify and develop effective therapies that positively alter the natural progression of these diseases, including Myotonic Dystrophy, myasthenia gravis, and chronic inflammatory polyneuropathies.
Education/Academic qualification
Research Fellowship, Baylor College of Medicine
Jul 1 1999 → Jun 30 2002
Award Date: Jun 30 2002
Neurology, Residency, Baylor College of Medicine
Jul 1 1996 → Jun 30 1999
Award Date: Jun 30 1999
Internal Medicine, Internship, Baylor College of Medicine
Jun 24 1995 → Jun 23 1996
Award Date: Jun 23 1996
MD, University of Texas at Houston Medical School
Jun 15 1992 → Jun 30 1995
Award Date: Jun 2 1995
Free-text keywords
- Neurology
- ALS
- Biomarkers
- Dendritic cells
- MCP-1
- Microglia
- Stem cells
Research Area Keywords
- Neurosciences
- Regenerative Medicine
Fingerprint
- 7 Similar Profiles
Network
Projects
-
Phase 2a_AT-1501_ALS AT-1501-A201
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
10/30/20 → …
Project: Clinical Trial
-
Radicava® (Edaravone) Findings in Biomarkers From ALS (REFINE-ALS)
Shroff, S., Appel, S. H., Greene, E. P. & Thonhoff, J. R.
10/20/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen A Zilucoplan
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/20/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen B Verdiperstat
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/19/20 → …
Project: Clinical Trial
-
HEALEY ALS Platform Trial - Regimen C CNM-Au8
Appel, S. H., Greene, E. P., Liao, B., Shroff, S. & Thonhoff, J. R.
8/19/20 → …
Project: Clinical Trial
Research Output
-
Placebo effect in chronic inflammatory demyelinating polyneuropathy: The PATH study and a systematic review
Lewis, R. A., Cornblath, D. R., Hartung, H. P., Sobue, G., Lawo, J. P., Mielke, O., Durn, B. L., Bril, V., Merkies, I. S. J., Bassett, P., Cleasby, A., van Schaik, I. N., Sabet, A., George, K., Roberts, L., Carne, R., Blum, S., Henderson, R., Van Damme, P., Demeestere, J. & 128 others, , Sep 1 2020, In : Journal of the Peripheral Nervous System. 25, 3, p. 230-237 8 p.Research output: Contribution to journal › Article
Open Access -
Spinal Cord and Motor Neuron TDP-43 Pathology in a Sporadic Inclusion Body Myositis Patient
Cathcart, S. J., Greene, E. P., Powell, S. Z., Arumanayagam, A. S., Rivera, A. L., Tawil, R., Appel, S. H. & Cykowski, M. D., Oct 1 2020, In : Journal of Neuropathology and Experimental Neurology. 79, 10, p. 1130-1133 4 p.Research output: Contribution to journal › Article
Open Access -
Efficacy and safety of IVIG in CIDP: Combined data of the PRIMA and PATH studies
on Behalf of the PRIMA Trial Investigators and the PATH Study Group, Mar 2019, In : Journal of the Peripheral Nervous System. 24, 1, p. 48-55 8 p.Research output: Contribution to journal › Article
7 Scopus citations -
Immune-Mediated Neuropathies
Fadia, M., Shroff, S. & Simpson, E., Jun 1 2019, In : Current Treatment Options in Neurology. 21, 6, 28.Research output: Contribution to journal › Review article
2 Scopus citations -
Rasagiline for amyotrophic lateral sclerosis: A randomized, controlled trial
The Rasagiline Investigators of the Muscle Study Group and Western ALS Consortium, Feb 1 2019, In : Muscle and Nerve. 59, 2, p. 201-207 7 p.Research output: Contribution to journal › Article
11 Scopus citations